# Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

> **NCT01937338** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 60 (actual)

## Conditions studied

- LPS Challenge, Neutrophils

## Interventions

- **DRUG:** AZD7624
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01937338
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01937338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01937338, "Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01937338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*